Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Currently it is in phase I trials for patients with advanced haematological tumours
D-alpha-Hydroxyglutaric acid disodium
CAS Number: 638156-11-3
which may contribute to the formation and malignant progression of gliomas as well as other forms of cancer
CAS# 935666-88-9
PX-478 - Hypoxia-inducible Factor-1α (HIF-1α) Inhibitor. CAS# 685898-44-6 0418 Currently it is in phasePX 478, CAS No. 685898 44 6, is HIF 1alpha inhibitor, is also an orally active small molecule with potential antineoplastic activity. Although its mechanism of action has yet to be fully elucidated, HIF1 alpha inhibitor PX 478 appears to inhibit hypoxia inducible factor 1 alpha (HIF1A) expression, which may result in decreased expression of HIF1A downstream target genes important to tumor growth and survival, a reduction in tumor cell proliferation,
US$ 20.00
US$ 22.00
US$ 20.00
US$ 32.00
US$ 1163.50
US$ 22.00
US$ 32.00
US$ 20.00
US$ 1944.00
US$ 1609.00
US$ 20.00